First Flu Vax Made with GMO Insect Cells Hits the Market
Ever aggressive in the quest to increase profits and consumer acceptance, the pharmaceutical industry has come up with a way to bypass the egg problem with the flu vaccine while simultaneously improving the bottom line.
Using proteins derived from GMO insect cells developed with the help of your tax dollars!
GMO vaccines are not something on the horizon either.
They are here.
Reports indicate that the FDA has very recently approved the first GMO vaccine known by the name Flublok.
The jab contains baculovirus, a GMO version of the insect virus created using recombinant DNA technology. Use of the technology is expected to speed production of vaccines, no doubt paving the way for a highly profitable product.
The Flublok package insert indicates that the vaccine is trivalent, meaning GM proteins from three different flu strains are used.
Instead of cells from egg cultures, Flublok is manufactured by Protein Sciences Corporation (PSC) using cells from the fall armyworm, a type of caterpillar.
The armyworm cells are genetically altered to produce large amounts of hemagglutinin, which is a flu virus protein that permits the flu virus itself to enter the human body more quickly.
Potential side effects from Flublok include allergic reactions, respiratory infections, headaches, fatigue, altered immunocompetence, rhinorrhea, and myalgia.
The package insert also warns that “careful consideration of the potential benefits and risks” of Flublok should be evaluated if the deadly nerve disease Gullain-Barre Syndrome (GSB) occurred within six weeks of receiving a prior flu vaccine.
Hard to believe someone who got Gullain-Barre from a prior flu jab would come back for more, don’t you think?
Most worrisome of all is that 2 study participants actually died during clinical trials of Flublok. True to pharmaceutical industry form, Protein Sciences Corporation insists the shot is safe, however, emphasizing that this new GMO shot is effective 45% of the time against all strains of flu and not just one or two.
It seems that the pharmaceutical industry is banking on the fact that even though the majority of people don’t want to eat GMOs, they will be willing to inject them.
Thanks but no thanks.
Sarah, The Healthy Home Economist
Two vaccine participants die during trials of the first GMO flu vaccine
Sarah Pope has been a Health and Nutrition Educator since 2002. She serves on the Board of Directors for the Weston A. Price Foundation.
Sarah was awarded Activist of the Year at the International Wise Traditions Conference in 2010.
Sarah earned a Bachelor of Arts (summa cum laude, Phi Beta Kappa) in Economics from Furman University and a Master’s degree in Government (Financial Management) from the University of Pennsylvania.
Mother to three healthy children, blogger, and best-selling author, she writes about the practical application of Traditional Diet and evidence-based wellness within the modern household. Her work has been featured by USA Today, The New York Times, National Review, ABC, NBC, and many others.